InsiderTrades.com logo
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

AVTX Insider Trading

Insider Ownership Percentage: 45.40%
Insider Buying (Last 12 Months): $9,206.86
Insider Selling (Last 12 Months): $0.00

Avalo Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Avalo Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avalo Therapeutics Share Price & Price History

Current Price: $1.75
Price Change: ▲ Price Increase of +0.14 (8.70%)
As of 03/30/2023 01:00 AM ET

This chart shows the closing price history over time for AVTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

Avalo Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2022Garry Arthur NeilCEOBuy2,083$4.42$9,206.869,220View SEC Filing Icon  
3/14/2022Armistice Capital, LlcDirectorBuy100,000$0.65$65,000.00View SEC Filing Icon  
3/10/2022Armistice Capital, LlcDirectorBuy26,000$0.70$18,200.00View SEC Filing Icon  
3/7/2022Armistice Capital, LlcDirectorBuy325,000$0.66$214,500.00View SEC Filing Icon  
3/3/2022Armistice Capital, LlcDirectorBuy50,000$0.71$35,500.00View SEC Filing Icon  
2/24/2022Armistice Capital, LlcDirectorBuy100,000$0.80$80,000.00View SEC Filing Icon  
2/22/2022Armistice Capital, LlcDirectorBuy83,000$0.77$63,910.00View SEC Filing Icon  
2/17/2022Armistice Capital, LlcDirectorBuy150,000$0.81$121,500.00View SEC Filing Icon  
1/20/2022Armistice Capital, LlcDirectorBuy12,000$0.85$10,200.00View SEC Filing Icon  
1/18/2022Armistice Capital, LlcDirectorBuy206,300$0.88$181,544.00View SEC Filing Icon  
1/14/2022Armistice Capital, LlcDirectorBuy85,000$0.93$79,050.00View SEC Filing Icon  
1/12/2022Armistice Capital, LlcDirectorBuy57,300$1.04$59,592.00View SEC Filing Icon  
1/10/2022Armistice Capital, LlcDirectorBuy491,097$0.99$486,186.03View SEC Filing Icon  
1/7/2022Armistice Capital, LlcDirectorBuy137,900$1.04$143,416.00View SEC Filing Icon  
12/10/2021Christopher Ryan SullivanCAOBuy955$1.57$1,499.35View SEC Filing Icon  
12/10/2021H. Jeffrey WilkinsInsiderBuy6,371$1.57$10,002.47View SEC Filing Icon  
12/10/2021Schond L. GreenwayCFOBuy2,231$1.57$3,502.67View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

SEC Filings (Institutional Ownership Changes) for Avalo Therapeutics (NASDAQ:AVTX)

67.46% of Avalo Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AVTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Avalo Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2023Millennium Management LLC43,193$0.22M0.0%-15.3%0.459%Search for SEC Filing on Google Icon
2/15/2023Nantahala Capital Management LLC540,667$2.73M0.2%-1.3%5.746%Search for SEC Filing on Google Icon
2/14/2023Susquehanna International Group LLP18,671$95K0.0%N/A0.198%Search for SEC Filing on Google Icon
11/15/2022State Street Corp25,643$85K0.0%-91.7%0.272%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.221,982$0.74M0.0%-92.8%2.358%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.103,414$0.34M0.0%-91.7%1.099%Search for SEC Filing on Google Icon
11/14/2022Armistice Capital LLC3,964,666$13.16M0.2%-91.7%42.115%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.500,737$1.66M0.0%-91.7%5.319%Search for SEC Filing on Google Icon
11/10/2022Nantahala Capital Management LLC547,814$1.82M0.1%-91.8%5.819%Search for SEC Filing on Google Icon
10/27/2022Assenagon Asset Management S.A.15,646$52K0.0%N/A0.166%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.649,653$0.32M0.0%+23.8%6.901%Search for SEC Filing on Google Icon
8/15/2022State Street Corp307,736$0.15M0.0%-68.5%3.269%Search for SEC Filing on Google Icon
8/15/2022Nantahala Capital Management LLC6,710,327$3.36M0.2%-2.0%71.280%Search for SEC Filing on Google Icon
8/15/2022Opaleye Management Inc.450,000$0.23M0.1%-69.1%4.780%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC1,011,082$0.51M0.0%N/A10.740%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC340,032$0.17M0.0%-7.4%3.612%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp116,463$58K0.0%-78.2%1.237%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.524,884$0.38M0.0%-23.4%0.465%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC367,193$0.27M0.0%+819.1%0.326%Search for SEC Filing on Google Icon
5/13/2022Nantahala Capital Management LLC6,849,547$4.80M0.2%-4.1%6.073%Search for SEC Filing on Google Icon
5/12/2022Integral Health Asset Management LLC700,000$0.51M0.1%-56.9%0.621%Search for SEC Filing on Google Icon
5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056%Search for SEC Filing on Google Icon
4/25/2022Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038%Search for SEC Filing on Google Icon
2/15/2022Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344%Search for SEC Filing on Google Icon
2/15/2022LGL Partners LLC28,850$49K0.0%N/A0.026%Search for SEC Filing on Google Icon
2/14/2022Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018%Search for SEC Filing on Google Icon
2/14/2022Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp533,578$0.91M0.0%+3.1%0.475%Search for SEC Filing on Google Icon
2/1/2022Assenagon Asset Management S.A.582,718$0.99M0.0%-33.7%0.519%Search for SEC Filing on Google Icon
1/24/2022Strs Ohio38,400$65K0.0%-40.2%0.034%Search for SEC Filing on Google Icon
1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031%Search for SEC Filing on Google Icon
12/29/2021Hudson Bay Capital Management LP197,133$0.43M0.0%N/A0.176%Search for SEC Filing on Google Icon
11/16/2021Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC18,657$41K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP732,931$1.60M0.0%N/A0.653%Search for SEC Filing on Google Icon
11/16/2021Laurion Capital Management LP330,444$0.72M0.0%N/A0.294%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350%Search for SEC Filing on Google Icon
11/15/2021Atom Investors LP27,507$60K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/15/2021Voya Investment Management LLC21,854$48K0.0%N/A0.019%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP11,812$26K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/12/2021Aristides Capital LLC48,953$0.11M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/12/2021Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126%Search for SEC Filing on Google Icon
11/12/2021Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610%Search for SEC Filing on Google Icon
11/10/2021Creative Planning14,814$32K0.0%N/A0.013%Search for SEC Filing on Google Icon
11/10/2021Alliancebernstein L.P.19,100$42K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.3,716,943$8.10M0.0%N/A3.369%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC270,000$0.59M0.1%N/A0.245%Search for SEC Filing on Google Icon
11/8/2021Meeder Asset Management Inc.19,260$43K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG31,794$69K0.0%N/A0.029%Search for SEC Filing on Google Icon
11/2/2021Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund22,214$48K0.0%N/A0.020%Search for SEC Filing on Google Icon
11/2/2021Victory Capital Management Inc.15,788$34K0.0%N/A0.014%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC18,596$41K0.0%N/A0.017%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC52,000$0.11M0.0%N/A0.047%Search for SEC Filing on Google Icon
10/25/2021Minot Wealth Management LLC103,410$0.23M0.0%N/A0.094%Search for SEC Filing on Google Icon
10/22/2021Strs Ohio64,200$0.14M0.0%N/A0.058%Search for SEC Filing on Google Icon
10/19/2021Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797%Search for SEC Filing on Google Icon
10/19/2021Tamar Securities LLC23,084$50K0.0%N/A0.021%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Avalo Therapeutics logo
Avalo Therapeutics, Inc. is a biopharmaceutical company. engages in the development and commercialization of treatments for rare and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as congenital disorders of glycosylation. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.
Read More on Avalo Therapeutics

Today's Range

Now: $1.75
Low: $1.63
High: $1.75

50 Day Range

MA: $2.90
Low: $1.61
High: $4.90

52 Week Range

Now: $1.75
Low: $1.41
High: $11.28

Volume

5,545 shs

Average Volume

18,178 shs

Market Capitalization

$16.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

Who are the company insiders with the largest holdings of Avalo Therapeutics?

Avalo Therapeutics' top insider shareholders include:
  1. Garry Arthur Neil (CEO)
  2. Armistice Capital, Llc (Director)
  3. Christopher Ryan Sullivan (CAO)
  4. H Jeffrey Wilkins (Insider)
  5. Schond L Greenway (CFO)
Learn More about top insider investors at Avalo Therapeutics.

Who are the major institutional investors of Avalo Therapeutics?

Avalo Therapeutics' top institutional shareholders include:
  1. Nantahala Capital Management LLC — 5.75%
  2. Millennium Management LLC — 0.46%
  3. Susquehanna International Group LLP — 0.20%
  4. Group One Trading L.P. — 0.00%
  5. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Avalo Therapeutics stock.

Which major investors are selling Avalo Therapeutics stock?

During the previous quarter, AVTX stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Nantahala Capital Management LLC

Which major investors are buying Avalo Therapeutics stock?

Within the last quarter, AVTX stock was acquired by institutional investors including:
  1. Susquehanna International Group LLP
During the previous year, these company insiders have bought Avalo Therapeutics stock:
  1. Garry Arthur Neil (CEO)
  2. Armistice Capital, Llc (Director)
  3. Christopher Ryan Sullivan (CAO)
  4. H Jeffrey Wilkins (Insider)
  5. Schond L Greenway (CFO)
Learn More investors buying Avalo Therapeutics stock.
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel